vorinostat has been researched along with Cancer of Muscle in 1 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
Excerpt | Relevance | Reference |
---|---|---|
"Treatment with Vorinostat/JQ1 inhibited glycolysis/MTOR signaling, activated the clock, and upregulated the UPR and autophagy via inhibition of YAP1/NF-κB." | 1.48 | YAP1 enhances NF-κB-dependent and independent effects on clock-mediated unfolded protein responses and autophagy in sarcoma. ( Babichev, Y; C Brady, D; Chor, S; E Ciotti, G; E Marino, G; Egolf, S; Eisinger-Mathason, TSK; Gladdy, R; Koumenis, C; Leli, NM; Liu, Y; Mancuso, A; Pak, K; Park, PMC; Posimo, JM; Qi, J; Rivera-Reyes, A; Sostre-Colón, J; Tameire, F; Weber, K; Ye, S, 2018) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rivera-Reyes, A | 1 |
Ye, S | 1 |
E Marino, G | 1 |
Egolf, S | 1 |
E Ciotti, G | 1 |
Chor, S | 1 |
Liu, Y | 1 |
Posimo, JM | 1 |
Park, PMC | 1 |
Pak, K | 1 |
Babichev, Y | 1 |
Sostre-Colón, J | 1 |
Tameire, F | 1 |
Leli, NM | 1 |
Koumenis, C | 1 |
C Brady, D | 1 |
Mancuso, A | 1 |
Weber, K | 1 |
Gladdy, R | 1 |
Qi, J | 1 |
Eisinger-Mathason, TSK | 1 |
1 other study available for vorinostat and Cancer of Muscle
Article | Year |
---|---|
YAP1 enhances NF-κB-dependent and independent effects on clock-mediated unfolded protein responses and autophagy in sarcoma.
Topics: Activating Transcription Factor 6; Adaptor Proteins, Signal Transducing; Animals; Autophagy; Azepine | 2018 |